Literature DB >> 15071014

Simple Algorithm for Identification of Bordetella pertussis Pertactin Gene Variants.

Gaëtan Muyldermans1, Denis Piérard, Nathalie Hoebrekx, Reza Advani, Shirley Van Amersfoorth, Iris De Schutter, Oriane Soetens, Leo Eeckhout, Anne Malfroot, Sabine Lauwers.   

Abstract

Studies performed in several countries have demonstrated the recent emergence and subsequent dominance of circulating Bordetella pertussis strains harboring pertactin and pertussis toxin variants not included in pertussis vaccines. Determination of the pertactin gene variants is commonly performed using a time-consuming and expensive sequence analysis. We developed a simple and reliable pertactin typing algorithm suitable for large-scale screening. The assay correctly identified all pertactin alleles in representative strains. The typing of 231 clinical strains of B. pertussis routinely isolated in Belgium showed that this algorithm was adequate to identify less-frequent prn types like prn9 and prn11.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071014      PMCID: PMC387558          DOI: 10.1128/JCM.42.4.1614-1619.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children.

Authors:  Paola Mastrantonio; Patrizia Spigaglia; Hans van Oirschot; Han G J van der Heide; Kees Heuvelman; Paola Stefanelli; Frits R Mooi
Journal:  Microbiology       Date:  1999-08       Impact factor: 2.777

2.  Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology.

Authors:  F R Mooi; H Hallander; C H Wirsing von König; B Hoet; N Guiso
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-03       Impact factor: 3.267

3.  Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999.

Authors:  P Cassiday; G Sanden; K Heuvelman; F Mooi; K M Bisgard; T Popovic
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

4.  Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.

Authors:  C Weber; C Boursaux-Eude; G Coralie; V Caro; N Guiso
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.

Authors:  N K Fry; S Neal; T G Harrison; E Miller; R Matthews; R C George
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  Multilocus sequence typing of Bordetella pertussis based on surface protein genes.

Authors:  Inge H M van Loo; Kees J Heuvelman; Audrey J King; Frits R Mooi
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 7.  Systematic review of the effects of pertussis vaccines in children.

Authors:  Tom Jefferson; Melanie Rudin; Carlo DiPietrantonj
Journal:  Vaccine       Date:  2003-05-16       Impact factor: 3.641

8.  Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin.

Authors:  E Leininger; C A Ewanowich; A Bhargava; M S Peppler; J G Kenimer; M J Brennan
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

9.  Molecular typing of Bordetella pertussis isolates recovered from Belgian children and their household members.

Authors:  Iris De Schutter; Anne Malfroot; Isidoor Dab; Nathalie Hoebrekx; Gaëtan Muyldermans; Denis Piérard; Sabine Lauwers
Journal:  Clin Infect Dis       Date:  2003-05-21       Impact factor: 9.079

10.  Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis.

Authors:  J Mäkinen; M K Viljanen; J Mertsola; H Arvilommi; Q He
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

View more
  6 in total

1.  Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains.

Authors:  Olga Borisova; Svetlana Yu Kombarova; Nelli S Zakharova; Marjolein van Gent; Vladimir A Aleshkin; Isabella Mazurova; Frits R Mooi
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

2.  Comparison of Western immunobloting to an enzyme-linked immunosorbent assay for the determination of anti-Bordetella pertussis antibodies.

Authors:  Stephen D Merrigan; Ryan J Welch; Christine M Litwin
Journal:  Clin Vaccine Immunol       Date:  2011-02-09

3.  Pertussis outbreak, southeastern Minnesota, 2012.

Authors:  Alexander G Theofiles; Scott A Cunningham; Nicholas Chia; Patricio R Jeraldo; Daniel J Quest; Jayawant N Mandrekar; Robin Patel
Journal:  Mayo Clin Proc       Date:  2014-10       Impact factor: 7.616

4.  Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012.

Authors:  H Bailon; N León-Janampa; C Padilla; D Hozbor
Journal:  BMC Infect Dis       Date:  2016-08-17       Impact factor: 3.090

5.  Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.

Authors:  Shane Byrne; Andrew T Slack
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

6.  Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines.

Authors:  Aldert Zomer; Nao Otsuka; Yukihiro Hiramatsu; Kazunari Kamachi; Naoko Nishimura; Takao Ozaki; Jan Poolman; Jeroen Geurtsen
Journal:  Microb Genom       Date:  2018-05-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.